Clinical Trial Update: Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever [Phase 3]

View source ↗

Summary

This Phase 3 trial update identifies factors that predict the efficacy of grass pollen injected allergen immunotherapy for seasonal allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Allergen immunotherapy (subcutaneous) (Subcutaneous immunotherapy with grass pollen extract)

Snippet

Sponsor: Imperial College London | Conditions: Rhinitis, Allergic, Seasonal | Phase 3 | Status: COMPLETED